The number of antipsychotic drug prescriptions for people with dementia rose with the advent of the COVID-19 pandemic, a troubling trend that suggests behavioral and psychological symptoms of dementia worsened during that time.
While neurologists will need to know whether a patient considering the new drug actually has signs of Alzheimer's, biomarker testing may not offer easy answers.
Difelikefalin was moderately effective for relieving itchiness in notalgia paresthetica, though it had some adverse events, a new study found. The authors suggest it could be used for other neuropathies that involve less severe burning and stingin...
See More Videos
This website uses cookies. By continuing to use this website you are giving consent to cookies being used. For information on cookies and how you can disable them visit our Privacy and Cookie Policy.
